Figure 4.

Platelet glycoprotein IIIa (GPIIIa) expression in aspirin-resistant vs. aspirin-sensitive subjects with coronary artery disease. (A) Typical Western blot of GPIIIa (125 kDa) and beta-actin (42 kDa), in platelets from an aspirin-resistant subject (ASP-R) compared to those from several aspirin-sensitive subjects. (B) Bar chart of expression of GPIIIa expressed relative to beta-actin, as assessed by Western blotting. ASP-R and ASP-S refer to aspirin-resistant and aspirin-sensitive subjects respectively. ** P < 0.01 vs. aspirin-sensitive subjects